Skip to main content
Year archive

Cipla Ltd. — 2022 filings

All 275 regulatory filings released by Cipla Ltd. (CIPLA) in 2022, sourced directly from the official regulator.

275 Filings
2022 Period
2022 filings (275)
Filing Released Lang
Press Release
Capital/Financing Update
2022-12-30 English
Acquisition
Capital/Financing Update
2022-12-30 English
Cipla EU to invest EUR 15 million in Ethris, initiating a strategic collaboration
Capital/Financing Update
2022-12-29 English
We hereby notify that Cipla (EU) Limited, United Kingdom, wholly owned subsidiary of Cipla Limited, has entered into definitive agreements on 29th December 2022 for acquisition of ~10.35% ....
Capital/Financing Update
2022-12-29 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2023 ,inter alia, to consider and approve unaudited standalone and consolidated ....
Regulatory Filings
2022-12-29 English
Board Meeting — Financial Results
Board/Management Information
2022-12-29 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2022-12-22 English
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee ....
Share Issue/Capital Change
2022-12-22 English
Loss of share certificate
Regulatory Filings
2022-12-09 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI Listing Regulations, we would like to inform you that M/s. KFin Technologies Limited, Registrar and Transfer Agent ....
Regulatory Filings
2022-12-09 English
Loss of share certificate
Regulatory Filings
2022-12-06 English
Pursuant to Regulation 39(3) of the SEBI Listing Regulations and in terms of SEBI Circular No. SEBI/HO/MIRSD/ MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022, the Company has approved ....
Regulatory Filings
2022-12-06 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-12-06 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations') we herein mention the ....
Regulatory Filings
2022-12-06 English
Press Release
Regulatory Filings
2022-11-29 English
Press Release - Cipla announces launch of Leuprolide Acetate injection depot (22.5mg).
Regulatory Filings
2022-11-29 English
Loss of share certificate
Regulatory Filings
2022-11-24 English
Loss of share certificate
Regulatory Filings
2022-11-24 English
Intimation for loss of share certificate as per Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Regulatory Filings
2022-11-24 English
Intimation regarding issuance of Letter of Confirmation under Regulation 39(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 ('Listing Regulations').
Regulatory Filings
2022-11-24 English
General updates
Regulatory Filings
2022-11-24 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in furtherance to intimation dated 26th August, 2022 for United States Food ....
Regulatory Filings
2022-11-24 English
ESOP/ESPS/SBEB Scheme
Share Issue/Capital Change
2022-11-21 English
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee ....
Share Issue/Capital Change
2022-11-21 English
Related Party Transaction
Regulatory Filings
2022-11-18 English
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of related party transactions for the ....
Regulatory Filings
2022-11-18 English
Intimation for loss of share certificate as per Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-11-15 English
Loss of share certificate
Regulatory Filings
2022-11-15 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript
2022-11-08 English
We are enclosing herewith copy of the transcript of the Company''s Q2 FY23 earnings conference call dated 4th November, 2022. The transcript is also available on the Company''s website ....
Call Transcript
2022-11-08 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-11-04 English
Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the audio recording of the earnings conference ....
Regulatory Filings
2022-11-04 English
ESOP/ESPS/SBEB Scheme
Capital/Financing Update
2022-11-04 English
This is to inform you that the Company has made the following grants in terms of the Employee Stock Option Scheme 2013-A ('ESOS 2013-A') and the Cipla Employee Stock Appreciation Rights ....
Regulatory Filings
2022-11-04 English
General updates
Regulatory Filings
2022-11-04 English
Update on intimation dated 25th January 2022 under Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements), Regulations 2015 ('Listing ....
Regulatory Filings
2022-11-04 English
In furtherance to our intimation dated 4th November 2022 under Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify the ....
Board/Management Information
2022-11-04 English
Outcome of Board Meeting
Regulatory Filings
2022-11-04 English
Newspaper Advertisements
Interim / Quarterly Report
2022-11-04 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing Consolidated Unaudited Financial Results for the quarter & half ....
Interim / Quarterly Report
2022-11-04 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation dated 4th November, 2022.
Investor Presentation
2022-11-04 English
Investor Presentation
Investor Presentation
2022-11-04 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Press Release dated 4th November, 2022.
Interim / Quarterly Report Q2 2023
2022-11-04 English
Press Release
Interim / Quarterly Report Q2 2023
2022-11-04 English
The Board of the Directors of the Company at its meeting held today i.e. 4th November 2022, has inter-alia approved the Unaudited Financial Results (standalone and consolidated) for the ....
Interim / Quarterly Report
2022-11-04 English
Outcome of Board Meeting
Regulatory Filings
2022-11-04 English
We are enclosing herewith the revised timing of the Earnings Conference Call scheduled on 4th November, 2022.
Earnings Release Q2 2023
2022-11-02 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Earnings Release Q2 2023
2022-11-02 English
ESOP/ESPS/SBEB Scheme
Share Issue/Capital Change
2022-10-19 English
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee ....
Share Issue/Capital Change
2022-10-19 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Earnings Release Q2 2023
2022-10-18 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings ....
Regulatory Filings
2022-10-17 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2022 ,inter alia, to consider and approve This is to inform you that a meeting ....
Board/Management Information
2022-10-11 English
Board Meeting — Financial results
Board/Management Information
2022-10-11 English
Cipla's Indore plant joins the World Economic Forum's (WEF) prestigious Lighthouse Network
Regulatory Filings
2022-10-11 English
Press Release
Regulatory Filings
2022-10-11 English
Pursuant to Regulation 39(3) of the SEBI LODR Regulations and in terms of SEBI Circular No. SEBI/HO/MIRSD/ MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022, the Company has approved the ....
Regulatory Filings
2022-09-27 English
General updates
Regulatory Filings
2022-09-22 English
Further to the intimation dated 4th July, 2022, this is to inform you that following the product specific Pre-Approval Inspection (PAI) by the United States Food and Drug Administration ....
Regulatory Filings
2022-09-22 English
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative ....
Share Issue/Capital Change
2022-09-14 English
ESOP/ESPS/SBEB Scheme
Share Issue/Capital Change
2022-09-14 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-09-13 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations') we herein mention the ....
Regulatory Filings
2022-09-13 English
Intimation of Schedule of Analyst / Institutional Investor Meeting
Regulatory Filings
2022-09-12 English
General updates
Call Transcript
2022-09-07 English
Please find enclosed the transcript of the 86th Annual General Meeting of the Company held on 26th August, 2022 through video conferencing / other audio-visual means. This transcript will ....
AGM Information
2022-09-07 English
Press Release
Regulatory Filings
2022-09-07 English
Cipla receives USFDA approval for generic version of Revlimid® (Lenalidomide capsules).
Regulatory Filings
2022-09-07 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Investor Presentation
2022-09-06 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached schedule of Analyst / Institutional ..
Regulatory Filings
2022-09-06 English
Loss of share certificate
Regulatory Filings
2022-09-02 English
Pursuant to Regulation 39(3) of the SEBI LODR Regulations and in terms of SEBI Circular No. SEBI/HO/MIRSD/ MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022, the Company has approved issuance ....
Regulatory Filings
2022-09-02 English
Cipla Limited hereby notify the Exchange that Cipla (EU) Limited, ("Cipla EU"), wholly owned subsidiary of the Company in UK has agreed to acquire an additional 13.10% stake in Cipla (Jiangsu) ....
Capital/Financing Update
2022-08-30 English
Acquisition
Capital/Financing Update
2022-08-30 English
Update on Agreement with Kemwell Biopharma Private Limited ("Kemwell India") for incorporation of a Joint Venture Company
Regulatory Filings
2022-08-30 English
General updates
Regulatory Filings
2022-08-30 English
General updates
Regulatory Filings
2022-08-26 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that further to United States Food and Drug Administration ....
Regulatory Filings
2022-08-26 English
Annual General Meeting
Declaration of Voting Results & Voting Rights Announcements
2022-08-26 English
Pursuant to Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing the voting results of the ....
Declaration of Voting Results & Voting Rights Announcements
2022-08-26 English
Annual General Meeting
AGM Information
2022-08-26 English
We hereby notify that the 86th Annual General Meeting (AGM) of the Company was held on Friday, 26th August 2022 at 3.00 pm through video conferencing / other audio-visual means (OAVM). ....
AGM Information
2022-08-26 English
This is to inform you that Cipla Medpro Holdings (Pty) Limited, wholly owned subsidiary of Cipla Medpro South Africa (Pty) Limited and a wholly owned step-down subsidiary of the Company, ....
Regulatory Filings
2022-08-26 English
General updates
Regulatory Filings
2022-08-26 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 17th ....
Regulatory Filings
2022-08-17 English
ESOP/ESPS/SBEB Scheme
Regulatory Filings
2022-08-17 English
General updates
Board/Management Information
2022-08-16 English
We wish to inform that, the Board of Directors of the Company at its meeting held on 16th August, 2022 has approved the changes in the Key Managerial Personnel (KMPs) authorised under Regulation ....
Board/Management Information
2022-08-16 English
The Board of Directors at its meeting held today i.e. August 16, 2022, has approved the appointment of Mr. Ashish Adukia as the Global Chief Financial Officer and Key Managerial Personnel ....
Board/Management Information
2022-08-16 English
Appointment
Board/Management Information
2022-08-16 English
Cipla Limited has informed the Exchange about relieving Mr. Dinesh Jain from the additional responsibility of interim Chief Financial Officer of the company w.e.f. 16-Aug-2022. Mr. Dinesh ....
Board/Management Information
2022-08-16 English
Resignation
Board/Management Information
2022-08-16 English
Cipla (EU) Limited, ("Cipla EU"), wholly owned subsidiary of the Company in UK, has agreed to acquire an additional 19.16% stake in Cipla Maroc SA, joint venture and subsidiary of Cipla EU in Morocco.
Capital/Financing Update
2022-08-04 English
Acquisition
Capital/Financing Update
2022-08-04 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Registrar and ....
Regulatory Filings
2022-08-04 English
Loss of share certificate
Regulatory Filings
2022-08-04 English
Newspaper Advertisements
AGM Information
2022-08-03 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copies of newspaper advertisements published in Business ....
Regulatory Filings
2022-08-03 English
Loss of share certificate
Regulatory Filings
2022-08-03 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Registrar and ....
Major Shareholding Notification
2022-08-03 English
Notice of the 86th Annual General Meeting along with copy of Integrated Annual Report for FY 2021-22
AGM Information
2022-08-02 English
Business Responsibility & Sustainability Report (BRSR)
Environmental & Social Information
2022-08-02 English
Pursuant to Regulations 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Business Responsibility and Sustainability Report ....
Environmental & Social Information
2022-08-02 English
Annual General Meeting
AGM Information
2022-08-02 English
Notice of the 86th Annual General Meeting along with copy of Integrated Annual Report for FY 2021-22
AGM Information
2022-08-02 English
Loss of share certificate
Regulatory Filings
2022-08-02 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Registrar and ....
Major Shareholding Notification
2022-08-02 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript
2022-08-02 English
We are enclosing herewith copy of the transcript of the Company''s Q1 FY23 earnings conference call dated 29th July, 2022. The transcript is also available on the Company''s website i.e., ....
Call Transcript
2022-08-02 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-07-29 English
Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the audio recording of the earnings call is ....
Regulatory Filings
2022-07-29 English
Investor Presentation
Interim / Quarterly Report
2022-07-29 English
We refer the investor presentation submitted through letter dated 29th July 2022. Please note that there was a minor error in the graphical presentation of the information in slide 11 (titled ....
Investor Presentation
2022-07-29 English
Appointment
Board/Management Information
2022-07-29 English
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations''), we hereby notify that on the recommendation ....
Board/Management Information
2022-07-29 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing an extract of the newspaper publications of Consolidated Unaudited ....
Interim / Quarterly Report Q1 2023
2022-07-29 English
Newspaper Advertisements
Interim / Quarterly Report
2022-07-29 English
Outcome of Board Meeting
Regulatory Filings
2022-07-29 English
In furtherance to our intimation dated 29th July, 2022 under Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board ....
Regulatory Filings
2022-07-29 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation dated 29th July, 2022.
Investor Presentation
2022-07-29 English
Investor Presentation
Investor Presentation
2022-07-29 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Press Release dated 29th July, 2022.
Interim / Quarterly Report Q1 2023
2022-07-29 English
Press Release
Interim / Quarterly Report
2022-07-29 English
The Board of the Directors of the Company at its meeting held today i.e. 29th July 2022, has inter-alia approved the Unaudited Financial Results (standalone and consolidated) for the quarter ....
Interim / Quarterly Report
2022-07-29 English
Outcome of Board Meeting
Interim / Quarterly Report
2022-07-29 English
Newspaper Advertisements
AGM Information
2022-07-28 English
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and in compliance with various circulars issued by the Ministry of Corporate Affairs, ....
AGM Information
2022-07-28 English
Loss of share certificate
Regulatory Filings
2022-07-27 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Registrar and ....
Major Shareholding Notification
2022-07-27 English
Record Date
Notice of Dividend Amount
2022-07-27 English
This is further to our letter dated 10th May, 2022, wherein it was informed that the Board of Directors of the Company have inter-alia recommended final dividend of Rs. 5/- per equity share ....
Notice of Dividend Amount
2022-07-27 English
General updates
Transaction in Own Shares
2022-07-26 English
Pursuant to Regulation 30 of the Listing Regulations, we hereby notify that lnvaGen Pharmaceuticals Inc., wholly owned step-down subsidiary of the Company in USA has entered into a Share ....
Capital/Financing Update
2022-07-26 English
Loss of share certificate
Major Shareholding Notification
2022-07-20 English
Pursuant to Regulation 39(3) of the SEBI LODR Regulations and in terms of SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022, the Company has approved issuance ....
Major Shareholding Notification
2022-07-20 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-07-20 English
Further to our intimation dated 15th July, 2022, the diamond pass link for earnings conference call registration, if not accessible, is annexed for reference.
Earnings Release Q1 2023
2022-07-20 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings ....
Call Transcript
2022-07-15 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Capital/Financing Update
2022-07-15 English
Cipla Health signs agreement to acquire Endura Mass
Capital/Financing Update
2022-07-14 English
Press Release
Capital/Financing Update
2022-07-14 English
Loss of share certificate
Major Shareholding Notification
2022-07-13 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Registrar and ....
Major Shareholding Notification
2022-07-13 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 11th ....
Regulatory Filings
2022-07-12 English
ESOP/ESPS/SBEB Scheme
Share Issue/Capital Change
2022-07-12 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2022 ,inter alia, to consider and approve the unaudited standalone and consolidated ....
Regulatory Filings
2022-07-08 English
Board Meeting — Financial results
Regulatory Filings
2022-07-08 English
Loss of share certificate
Regulatory Filings
2022-07-05 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that our Registrar ....
Regulatory Filings
2022-07-05 English
We hereby notify that the United States Food and Drug Administration ("US FDA") conducted a Pre- Approval Inspection ("PAI") at the Company''s Indore plant from 27th June 2022 to 1st July ....
Regulatory Filings
2022-07-04 English
General updates
Regulatory Filings
2022-07-04 English
Press Release - Cipla to further invest in digital tech company GoApptiv; to hold 22.02% stake post completion of proposed transaction.
Capital/Financing Update
2022-06-27 English
Press Release
Capital/Financing Update
2022-06-27 English
Acquisition
Capital/Financing Update
2022-06-27 English
Cipla Limited has entered into definitive agreements on 27th June 2022 for further investment of Rs. 25.90 crores (approx.) in GoApptiv Private Limited.
Regulatory Filings
2022-06-27 English
Newspaper Advertisements
Regulatory Filings
2022-06-24 English
Please find the enclosed herewith copies of newspaper advertisement of Notice to Shareholders whose shares are liable to be transferred to Investor Education and Protection Fund ("IEPF") ....
Regulatory Filings
2022-06-24 English
Cipla signs agreement for acquisition of 21.05% stake in Achira Labs to develop affordable, innovative medical kits in India
Regulatory Filings
2022-06-17 English
Cipla signs agreement for acquisition of 21.05% stake in Achira Labs to develop affordable, innovative medical kits in India
Regulatory Filings
2022-06-17 English
Press Release
Capital/Financing Update
2022-06-17 English
Cipla has entered into definitive agreements on 17th June 2022 for the acquisition of 21.05% stake (on a fully diluted basis) in Achira Labs Private Limited.
Regulatory Filings
2022-06-17 English
Acquisition
Capital/Financing Update
2022-06-17 English
Press Release
Regulatory Filings
2022-06-14 English
Please find enclosed press release dated 14th June 2022 for the captioned subject.
Regulatory Filings
2022-06-14 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-06-10 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached schedule of Analyst / Institutional ..
Regulatory Filings
2022-06-10 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 10th ....
Share Issue/Capital Change
2022-06-10 English
ESOP/ESPS/SBEB Scheme
Share Issue/Capital Change
2022-06-10 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-06-06 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached schedule of Analyst / Institutional ..
Regulatory Filings
2022-06-06 English
Loss of share certificate
Regulatory Filings
2022-06-02 English
Loss of share certificate
Regulatory Filings
2022-06-02 English
Pursuant to Regulation 39(3) and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Registrar and Transfer ....
Regulatory Filings
2022-06-02 English
Intimation under Regulation 39 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding loss of share certificate(s)
Regulatory Filings
2022-06-02 English
Press Release
Regulatory Filings
2022-06-02 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Press Release dated 2nd June 2022.
Regulatory Filings
2022-06-02 English
Press Release
Environmental & Social Information
2022-05-25 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Press Release dated 25th May 2022.
Environmental & Social Information
2022-05-25 English
Related Party Transaction
Regulatory Filings
2022-05-24 English
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of related party transactions on a consolidated ....
Interim / Quarterly Report H2 2022
2022-05-24 English
General updates
Regulatory Filings
2022-05-24 English
Pursuant to Regulation 24A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed the Annual Secretarial ....
Regulatory Filings
2022-05-24 English
Loss of share certificate
Regulatory Filings
2022-05-23 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Registrar and ....
Regulatory Filings
2022-05-23 English
ESOP/ESPS/SBEB Scheme
Share Issue/Capital Change
2022-05-20 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 20th ....
Share Issue/Capital Change
2022-05-20 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript
2022-05-17 English
We are enclosing herewith copy of the transcript of the Company's Q4 FY22 earnings conference call dated 10th May, 2022. The transcript is also available on the Company's website i.e. www.cipla.com ..
Call Transcript
2022-05-17 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-05-10 English
Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the audio recording of the earnings call is ....
Regulatory Filings
2022-05-10 English
General updates
Board/Management Information
2022-05-10 English
We wish to inform you that, the Board of Directors of the Company at its meeting held on 10th May 2022 has approved the changes in the Key Managerial Personnel (KMPs) authorized under Regulation ....
Board/Management Information
2022-05-10 English
General updates
Capital/Financing Update
2022-05-10 English
Please find enclosed letter dated 10th May 2022.
Share Issue/Capital Change
2022-05-10 English
Newspaper Advertisements
Interim / Quarterly Report FY 2022
2022-05-10 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing an extract of the Newspaper publications of consolidated audited ....
Interim / Quarterly Report FY 2022
2022-05-10 English
In furtherance to our intimation dated 10th May, 2022 under Regulation 30 and 33 of the SEBI (Listing Obligations Requirements) Regulations, 2015, the meeting of the Board of Directors ....
Board/Management Information
2022-05-10 English
Outcome of Board Meeting
Board/Management Information
2022-05-10 English
Please find enclosed Investor Presentation dated 10th May 2022.
Investor Presentation
2022-05-10 English
Investor Presentation
Investor Presentation
2022-05-10 English
Please find enclosed Press Release dated 10th May 2022.
Interim / Quarterly Report Q4 2022
2022-05-10 English
Press Release
Earnings Release Q4 2022
2022-05-10 English
Please find enclosed letter dated 10th May 2022
Regulatory Filings
2022-05-10 English
Dividend
Annual Report
2022-05-10 English
Financial Result Updates
Annual Report
2022-05-10 English
Please find enclosed letter dated 10th May 2022
Regulatory Filings
2022-05-10 English
Appointment
Board/Management Information
2022-05-10 English
Pursuant to Regulation 30(2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby notify that the Board of Directors, today, has appointed Mr. Dinesh ....
Board/Management Information
2022-05-10 English
Press Release
Regulatory Filings
2022-05-10 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Press Release dated 10th May, 2022.
Regulatory Filings
2022-05-10 English
We are enclosing herewith Compliance Certificate, duly signed by the Compliance Officer of the Company and the Registrar and Share Transfer Agent, KFin Technologies Limited (formerly known ....
Regulatory Filings
2022-04-29 English
Please find enclosed Certificate from a Practicing Company Secretary in compliance with Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure ....
Regulatory Filings
2022-04-29 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2022-04-22 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-04-20 English
Please find enclosed schedule of Earnings Conference Call to be held on 10th May, 2022.
Regulatory Filings
2022-04-20 English
Board Meeting — Dividend/Financial results
Regulatory Filings
2022-04-19 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2022 ,inter alia, to consider and approve This is to inform you that a meeting ....
Regulatory Filings
2022-04-19 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification
2022-04-11 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached schedule of Analyst / Institutional ..
Regulatory Filings
2022-03-21 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-03-21 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Investor Presentation
2022-03-07 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached schedule of Analyst / Institutional ..
Regulatory Filings
2022-03-07 English
This has reference to your email dated 25th February 2022 seeking clarification regarding recent news item which appeared in the 'economictimes.indiatimes.com' dated 24th February 2022 ....
Regulatory Filings
2022-02-27 English
News Verification
Regulatory Filings
2022-02-27 English
Loss of share certificate
Regulatory Filings
2022-02-27 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Registrar and ....
Regulatory Filings
2022-02-27 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-02-24 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached schedule of Analyst / Institutional ..
Regulatory Filings
2022-02-23 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 16th ....
Share Issue/Capital Change
2022-02-16 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2022-02-16 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Y K Hamied & PACs
Major Shareholding Notification
2022-02-15 English
We are enclosing a statement by Ms. Samina Hamied, Executive Vice Chairperson w.r.t sale of 2,01,69,756 shares by the promoters today i.e. February 15, 2022.
Major Shareholding Notification
2022-02-15 English
Updates
Major Shareholding Notification
2022-02-15 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached schedule of Analyst / Institutional ..
Regulatory Filings
2022-02-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-02-14 English
Updates
Regulatory Filings
2022-02-10 English
This is to inform you that in terms of de-registration notice issued by the Companies and Intellectual Property Commission, Republic of South Africa on 9th February 2022, Cipla Biotec South ....
Regulatory Filings
2022-02-10 English
Resignation
Board/Management Information
2022-02-04 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that Kedar Upadhye has, on February 4, 2022, resigned from the ....
Board/Management Information
2022-02-04 English
Acquisition
Capital/Financing Update
2022-02-04 English
In compliance with the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit that ....
Capital/Financing Update
2022-02-04 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached schedule of Analyst / Institutional ..
Regulatory Filings
2022-02-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-02-04 English
Please find enclosed copy of the transcript of the Company's Q3 FY22 earnings conference call dated 25th January, 2022. The transcript is also available on the Company's website i.e. www.cipla.com ...
Call Transcript
2022-01-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2022-01-29 English
Pursuant to the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('SEBI Listing Regulations') we ....
Board/Management Information
2022-01-26 English
Resignation
Board/Management Information
2022-01-26 English
Pursuant to the provisions of Regulation 30 of the SEBI Listing Regulations and further to the intimation dated 26th October 2021, we hereby notify that the Board of Directors of Cipla ....
Capital/Financing Update
2022-01-25 English
Updates
Capital/Financing Update
2022-01-25 English
In furtherance to our intimation dated 25th January 2022 under Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2022-01-25 English
Outcome of Board Meeting
Regulatory Filings
2022-01-25 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation dated 25th January, 2022.
Investor Presentation
2022-01-25 English
Investor Presentation
Investor Presentation
2022-01-25 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Press Release dated 25th ....
Earnings Release Q3 2022
2022-01-25 English
Press Release
Interim / Quarterly Report Q3 2022
2022-01-25 English
Copy of Newspaper Publication
Interim / Quarterly Report 9M 2022
2022-01-25 English
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing newspaper publication of the ....
Interim / Quarterly Report 9M 2022
2022-01-25 English
Financial Result Updates
Interim / Quarterly Report
2022-01-25 English
Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the following: ....
Interim / Quarterly Report
2022-01-25 English
We are enclosing herewith copy of the transcript of the Company's 40th Annual J.P. Morgan Healthcare Conference. The transcript is also available on the Company's website i.e. www.cipla.com ....
Call Transcript
2022-01-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2022-01-17 English
Please find enclosed schedule of Earnings Conference Call to be held on 25th January 2022.
Regulatory Filings
2022-01-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-01-17 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 14th ....
Share Issue/Capital Change
2022-01-14 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2022-01-14 English
Cipla wins the prestigious Frost & Sullivan and TERI's Sustainability 4.0 Award 2021 as 'Challenger in Mega Large Business Pharma Sector.
Environmental & Social Information
2022-01-13 English
Press Release
Environmental & Social Information
2022-01-13 English
Please find enclosed update on intimation dated 3rd November, 2021 on termination of Stock Purchase and Merger Agreement ('the SPMA') with Avenue Therapeutics Inc.
Regulatory Filings
2022-01-12 English
Acquisition
Regulatory Filings
2022-01-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2022-01-12 English
In furtherance to our intimation dated 11th January 2022 with respect to our participation at the 40th Annual J.P. Morgan Healthcare Conference, the presentation to be discussed at the ....
Investor Presentation
2022-01-12 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached schedule of Analyst / Institutional ..
Investor Presentation
2022-01-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-01-11 English
Loss of Share Certificates
Regulatory Filings
2022-01-06 English
In compliance with the requirements of Regulation 39 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated 15th December, 2021 ....
Regulatory Filings
2022-01-06 English